Category: BrightInsight

Digital tools key to immuno-oncology’s future: report

ASCO, BrightInsight, Deep Dive, Deep Dive: Oncology, digital health, Oncology, Views & Analysis, Views and analysis / July 23, 2021 July 23, 2021

If ASCO 2021 proves anything, it’s that the explosion in immuno-oncology therapies over the last few years shows no signs of slowing down. As the field becomes more crowded, digital tools may be critical for improving outcomes, says a new whitepaper. The whitepaper, ‘The Role of Digital Health in Immuno-oncology Therapy Development and Adoption’ from …

Digital tools key to immuno-oncology’s future: report Read More »

Regulated digital health explained: What you need to know to stay compliant [Sponsored]

BioPharma, BrightInsight, connected devices, Daily, EU, Health Tech, IoMT, MDR, Medical Devices, Pharma, Policy, sponsored content, Sponsored Post, SYN, Top Story / July 19, 2021 July 19, 2021

Digital health thought leader Mark Tarby, BrightInsight vice president of regulatory and quality management systems, shared his take on what the EU MDR means for connected devices, Software as a Medical Device (SaMD), and the go-to market strategies for the companies behind them.

#Healthin2Point00, Episode 197 | BrightInsight, SteadyMD, CirrusMD, and Cleo

BrightInsight, CirrusMD, cleo, Health in 2 Point 00, Health Tech, Health Technology, Jessica DaMassa, Matthew Holt / April 7, 2021 April 7, 2021

Today on Health in 2 Point 00, I’m getting my shots soon! On Episode 197, General Catalyst is throwing more money around – $101 million goes to BrightInsight for its digital health insights management platform. SteadyMD raises $25 million bringing its total to $31 million, and CirrusMD raises $20 million in a Series C bringing …

#Healthin2Point00, Episode 197 | BrightInsight, SteadyMD, CirrusMD, and Cleo Read More »

General Catalyst leads $101M investment in startup helping pharma build digital health tools

BrightInsight, Daily, digital health, General Catalyst, Health IT, Health Tech, San Jose, SYN, Top Story / March 30, 2021 March 30, 2021

BrightInsight, a startup developing infrastructure to make it easier for companies to make their own health apps, raised $101 million in funding. General Catalyst led the series C round.

AstraZeneca presses forward with digital approach to managing chronic conditions

AstraZeneca, BioPharma, biopharma nl, BrightInsight, chronic disease management, Daily, Health IT, Kal Patel, Karan Arora, Pharma, SYN, Top Story / March 16, 2021 March 16, 2021

AstraZeneca is turning to digital technology to help patients and clinicians manage the treatment of chronic diseases. Though this technology isn’t tied to any AstraZeneca drug, the company believes such digital tools will become part of the new standard of care.

How digital health impacts the development and adoption of cancer immunotherapies [Sponsored]

AstraZeneca, biopharma nl, BrightInsight, Bristol-Myers Squibb, cancer, Daily, digital health, Health IT, Health Tech, Immuno-Oncology, immunotherapies, Kal Patel, Medical Devices, News, Pharma, Precision Medicine, Sponsored Post, SYN, Top Story / March 3, 2021 March 3, 2021

In an interview, BrightInsight Co-founder and CEO Kal Patel, MD, offered a preview of the report, The Role of Digital Health in Immuno-oncology Therapy Development and Adoption.

Covid-19’s digital imperative for biopharma and medtech [Sponsored]

BioPharma, biopharma nl, BrightInsight, COVID-19, Daily, IoT, Medical Devices, Sponsored Post, Startups, SYN, Top Story / October 21, 2020 October 21, 2020

The disruption to biopharma and medtech businesses caused by Covid-19, such as product launch and clinical trial delays, has underscored the need for a more digital focused strategy.

Startups talk about what it’s like to raise money in a pandemic

BrightInsight, California, coronavirus, COVID-19, Daily, Evidation, invest 2020 virtual, San Mateo, SARS-CoV-2, Startups, SYN, Top Story / July 23, 2020 July 23, 2020

MedCity spoke with Evidation and BrightInsight, two startups that have recently announced funding rounds, amid a Covid-19 pandemic worsening in the U.S.